Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Lester

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 10, 2017
A Treat-to-Target Strategy Preserves Work Capacity in a Rheumatoid Arthritis Inception Cohort Treated With Combination Conventional DMARD TherapyMihir D Wechalekar, Stephen Quinn, Susan Lester, et al.
Frontiers in Medicine|May 8, 2023
Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014-2020Jem Ninan, Carlee Ruediger, Kathryn A Dyer, et al.
Internal Medicine Journal|June 21, 2025
The rheumatology workforce in Australia: current and projected shortfallsAlice M Terrett, Arvin Damodaran, Simon Burnet, et al.
Rheumatology (Oxford, England)|September 7, 2022
COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohortChristopher McMaster, David F L Liew, Susan Lester, et al.
Clinical and Experimental Rheumatology|May 24, 2016
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|November 20, 2013
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|January 19, 2015
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosisYanjie Hao, Vivek Thakkar, Wendy Stevens, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 26, 2026
A Pilot Randomised Controlled Dose-Ranging Trial of Ant Venom Immunotherapy With and Without Delta-Inulin AdjuvantThanh-Thao Adriana Le, Troy Wanandy, Griffith B Perkins, et al.
RMD Open|April 26, 2016
PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritisSusan Lester, Alex W Hewitt, Carlee D Ruediger, et al.
Scientific Reports|October 18, 2019
IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosisMayada Metwally, Khaled Thabet, Ali Bayoumi, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 10, 2017
A Treat-to-Target Strategy Preserves Work Capacity in a Rheumatoid Arthritis Inception Cohort Treated With Combination Conventional DMARD TherapyMihir D Wechalekar, Stephen Quinn, Susan Lester, et al.
Frontiers in Medicine|May 8, 2023
Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014-2020Jem Ninan, Carlee Ruediger, Kathryn A Dyer, et al.
Internal Medicine Journal|June 21, 2025
The rheumatology workforce in Australia: current and projected shortfallsAlice M Terrett, Arvin Damodaran, Simon Burnet, et al.
Rheumatology (Oxford, England)|September 7, 2022
COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohortChristopher McMaster, David F L Liew, Susan Lester, et al.
Clinical and Experimental Rheumatology|May 24, 2016
The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|November 20, 2013
The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyVivek Thakkar, Wendy Stevens, David Prior, et al.
Arthritis Research & Therapy|January 19, 2015
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosisYanjie Hao, Vivek Thakkar, Wendy Stevens, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 26, 2026
A Pilot Randomised Controlled Dose-Ranging Trial of Ant Venom Immunotherapy With and Without Delta-Inulin AdjuvantThanh-Thao Adriana Le, Troy Wanandy, Griffith B Perkins, et al.
RMD Open|April 26, 2016
PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritisSusan Lester, Alex W Hewitt, Carlee D Ruediger, et al.
Scientific Reports|October 18, 2019
IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosisMayada Metwally, Khaled Thabet, Ali Bayoumi, et al.
Pageof 11